Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort.

Urine Oxalate chronic kidney disease end-stage renal disease estimated glomerular filtration rate plasma oxalate primary hyperoxaluria

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
20 May 2020
Historique:
received: 01 04 2020
revised: 15 05 2020
accepted: 16 05 2020
entrez: 24 5 2020
pubmed: 24 5 2020
medline: 17 2 2021
Statut: epublish

Résumé

This retrospective analysis investigated plasma oxalate (POx) as a potential predictor of end-stage kidney disease (ESKD) among primary hyperoxaluria (PH) patients. PH patients with type 1, 2, and 3, age 2 or older, were identified in the Rare Kidney Stone Consortium (RKSC) PH Registry. Since POx increased with falling estimated glomerular filtration rate (eGFR), patients were stratified by chronic kidney disease (CKD) subgroups (stages 1, 2, 3a, and 3b). POx values were categorized into quartiles for analysis. Hazard ratios (HRs) and 95% confidence intervals (95% CIs) for risk of ESKD were estimated using the Cox proportional hazards model with a time-dependent covariate. There were 118 patients in the CKD1 group (nine ESKD events during follow-up), 135 in the CKD 2 (29 events), 72 in CKD3a (34 events), and 45 patients in CKD 3b (31 events). During follow-up, POx Q4 was a significant predictor of ESKD compared to Q1 across CKD2 (HR 14.2, 95% CI 1.8-115), 3a (HR 13.7, 95% CI 3.0-62), and 3b stages (HR 5.2, 95% CI 1.1-25),

Identifiants

pubmed: 32443777
pii: ijms21103608
doi: 10.3390/ijms21103608
pmc: PMC7279271
pii:
doi:

Substances chimiques

Biomarkers 0
Oxalates 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCATS NIH HHS
ID : R21 TR003174
Pays : United States
Organisme : NIDDK NIH HHS
ID : U54DK083908
Pays : United States

Références

Kidney Int. 2009 Jun;75(12):1264-1271
pubmed: 19225556
Clin Chem. 1991 Jul;37(7):1229-35
pubmed: 1855295
N Engl J Med. 2013 Aug 15;369(7):649-58
pubmed: 23944302
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Sep 15;873(1):31-6
pubmed: 18755640
Nephrol Dial Transplant. 2010 Jul;25(7):2341-5
pubmed: 20167571
N Engl J Med. 2012 Jul 5;367(1):20-9
pubmed: 22762315
Clin Biochem. 2017 Dec;50(18):1014-1019
pubmed: 28764885
Clin J Am Soc Nephrol. 2016 Jan 7;11(1):119-26
pubmed: 26656319
Am J Physiol Renal Physiol. 2013 Dec 1;305(11):F1574-84
pubmed: 24089413
Clin Chem. 2005 Dec;51(12):2377-80
pubmed: 16306102
Pediatr Nephrol. 2013 Oct;28(10):1923-42
pubmed: 23334384
Kidney Int. 1998 May;53(5):1348-52
pubmed: 9573551
World J Nephrol. 2015 May 6;4(2):235-44
pubmed: 25949937
Am J Nephrol. 2005 May-Jun;25(3):290-6
pubmed: 15961949
Mol Ther. 2016 Apr;24(4):770-8
pubmed: 26758691
J Am Soc Nephrol. 2009 Mar;20(3):629-37
pubmed: 19158356

Auteurs

Ronak Jagdeep Shah (RJ)

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.

Lisa E Vaughan (LE)

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA.

Felicity T Enders (FT)

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN 55905, USA.

Dawn S Milliner (DS)

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
Division of Pediatric Nephrology, Mayo Clinic, Rochester, MN 55905, USA.

John C Lieske (JC)

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905, USA.
Division of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH